Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B

Despite the availability of an effective preventive vaccine for hepatitis B virus (HBV) for over 38 years, chronic HBV (CHB) infection remains a global health burden with around 257 million patients. The ideal treatment goal for CHB infection would be to achieve complete cure; however, current thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzikouri, Sayeh, Hoque Kayesh, Mohammad Enamul, Benjelloun, Soumaya, Kohara, Michinori, Tsukiyama-Kohara, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349973/
https://www.ncbi.nlm.nih.gov/pubmed/32403281
http://dx.doi.org/10.3390/vaccines8020216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349973/
https://www.ncbi.nlm.nih.gov/pubmed/32403281
http://dx.doi.org/10.3390/vaccines8020216

Ejemplares similares